Develops innovative biologic therapies for serious musculoskeletal diseases like osteoporosis, osteogenesis imperfecta, and spinal fusion.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis, osteogenesis imperfecta (OI), and spinal fusion. Leveraging the team’s extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Angitia Biopharmaceuticals Management Team
Investors
3H Health Investment
Bain Capital
Elikon Venture
Janus Henderson
Legend Capital
OrbiMed Advisors
Yonghua Capital
Angitia Biopharmaceuticals Valuations & Financials
View real-time NPM data on Angitia Biopharmaceuticals stock including daily Angitia Biopharmaceuticals stock price estimates, valuation history, and historical share price information. Access Angitia Biopharmaceuticals financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Angitia Biopharmaceuticals pricing across six independent market signals. Looking for private company due diligence data sources on Angitia Biopharmaceuticals? Get in touch to learn more.
Similar Companies
like Angitia Biopharmaceuticals
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Lumeris
Healthcare & Life Sciences
Value-based care managed services operator for health systems and providers.
Kalibri Labs
Enterprise Software
A SaaS company that provides a benchmarking platform and reports to assess hotel performance in the digital marketplace.
Albert
FinTech
Comprehensive financial service that combines advanced technology with human expertise to automate and manage all aspects of personal finances.
MicroByre
Healthcare & Life Sciences
Engineering unconventional bacteria to convert biomass and waste into sustainable chemical feedstocks via precision fermentation.
Stability AI
AI & Machine Learning
Open-source AI company focused on developing groundbreaking technologies to benefit humanity.
Maven Machines
Commerce & Marketplaces
Delivers vehicle data analytics and safety insights to optimize operations and reduce risk.
Lithic
FinTech
Enables businesses to create and manage card programs, offering card issuing and processing services.
Illumix
Media & Entertainment
Enables AR interactions which overlay digital content onto real spaces for brand and venue experiences.
FAQ
We have answers
Angitia Biopharmaceuticals stock does not trade on public stock exchanges. Angitia Biopharmaceuticals stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Angitia Biopharmaceuticals stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Angitia Biopharmaceuticals Stock does not trade on public stock exchanges. In order to sell Angitia Biopharmaceuticals shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Angitia Biopharmaceuticals does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Angitia Biopharmaceuticals share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Angitia Biopharmaceuticals stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Angitia Biopharmaceuticals stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Angitia Biopharmaceuticals stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Angitia Biopharmaceuticals is a private company and has not had an IPO. There is currently no Angitia Biopharmaceuticals IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Angitia Biopharmaceuticals IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
